Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study

被引：0
|
作者：
Piero Barbanti
Cinzia Aurilia
Gabriella Egeo
Stefania Proietti
Florindo D’Onofrio
Paola Torelli
Marco Aguggia
Davide Bertuzzo
Cinzia Finocchi
Michele Trimboli
Sabina Cevoli
Giulia Fiorentini
Bianca Orlando
Maurizio Zucco
Laura Di Clemente
Ilaria Cetta
Bruno Colombo
Monica Laura Bandettini di Poggio
Valentina Favoni
Licia Grazzi
Antonio Salerno
Antonio Carnevale
Micaela Robotti
Fabio Frediani
Claudia Altamura
Massimo Filippi
Fabrizio Vernieri
Stefano Bonassi
机构：
[1] IRCCS San Raffaele Roma,Headache and Pain Unit
[2] San Raffaele University,Clinical and Molecular Epidemiology
[3] IRCCS San Raffaele Roma,Headache Center Neurology Unit
[4] San Giuseppe Moscati Hospital,Unit of Neurology, Department of Medicine and Surgery, Headache Center
[5] University of Parma,Headache Center
[6] Headache Center Cardinal Massaia,Neurology Unit, IRCCS San Raffaele Scientific Institute
[7] Divisione di Neurologia,Neuroalgology Unit, Headache Center Fondazione
[8] University Magna Graecia,Headache Center
[9] IRCCS Istituto delle Scienze Neurologiche di Bologna,Headache and Neurosonology Unit
[10] San Camillo-Forlanini Hospital,undefined
[11] Vita-Salute San Raffaele University,undefined
[12] IRCCS Ospedale Policlinico San Martino,undefined
[13] IRCCS Istituto Neurologico“Carlo Besta”,undefined
[14] Headache Center San Giovanni Addolorata Hospital,undefined
[15] Headache Center San Filippo Neri Hospital,undefined
[16] ASST Santi Paolo Carlo,undefined
[17] Policlinico Universitario Campus Bio-Medico,undefined
来源：
Journal of Neurology | 2024年 / 271卷
关键词：
Migraine; Treatment; Anti-CGRP mAbs; Responder; Late response; Ultra-late response; Real-life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2434 / 2443
页数：9
相关论文
共 50 条
  • [31] In Response to Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents
    Charles, James A.
    HEADACHE, 2020, 60 (01): : 271 - 272
  • [32] Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis
    Drellia, Konstantina
    Kokoti, Lili
    Deligianni, Christina, I
    Papadopoulos, Dimitrios
    Mitsikostas, Dimos D.
    CEPHALALGIA, 2021, 41 (07) : 851 - 864
  • [33] An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine
    Romozzi, Marina
    Lokhandwala, Ammar
    Vollono, Catello
    Vigani, Giulia
    Burgalassi, Andrea
    Garcia-Azorin, David
    Calabresi, Paolo
    Chiarugi, Alberto
    Geppetti, Pierangelo
    Iannone, Luigi Francesco
    CEPHALALGIA, 2024, 44 (12)
  • [34] Treatment and management of migraine in neurological ambulatory practice in Poland by indicating therapy with monoclonal anti-CGRP antibodies
    Domitrz, Izabela
    Lipa, Aurelia
    Rozniecki, Jacek
    Stepien, Adam
    Kozubski, Wojciech
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (04) : 337 - 343
  • [35] Could the New Anti-CGRP Monoclonal Antibodies Be Effective in Migraine Aura? Case Reports and Literature Review
    Albanese, Maria
    Mercuri, Nicola Biagio
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [36] A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody
    Kielbasa, William
    Helton, Danielle L.
    CEPHALALGIA, 2019, 39 (10) : 1284 - 1297
  • [37] Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine
    Ceccardi, Giulia
    di Cola, Francesca Schiano
    Caratozzolo, Salvatore
    Di Pasquale, Michele
    Bolchini, Marco
    Padovani, Alessandro
    Rao, Renata
    TOXINS, 2023, 15 (12)
  • [38] Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
    Caronna, Edoardo
    Jose Gallardo, Victor
    Alpuente, Alicia
    Torres-Ferrus, Marta
    Pozo-Rosich, Patricia
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01)
  • [39] Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
    Edoardo Caronna
    Victor José Gallardo
    Alicia Alpuente
    Marta Torres-Ferrus
    Patricia Pozo-Rosich
    The Journal of Headache and Pain, 2021, 22
  • [40] Anti-CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years
    Pons-Fuster, E.
    Lozano-Caballero, O.
    Martin-Balbuena, S.
    Lucas-Rodenas, C.
    Mancebo-Gonzalez, A.
    De Gorostiza-Frias, I.
    Gonzalez-Ponce, C. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, : 1317 - 1326
12345